Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 19552 Rp
2. Pipothiazin Palmitate
3. Pipothiazine Palmitate
4. Pipotiazin Retard
1. 37517-26-3
2. Pipothiazine Palmitate
3. Pipotiazine Palmitate [usan]
4. Rp 19552
5. Pipotiazine Palmitic Ester
6. 4q3h01qrmi
7. 19552 Rp
8. Il-19552
9. Rp-19552
10. 2-[1-[3-[2-(dimethylsulfamoyl)phenothiazin-10-yl]propyl]piperidin-4-yl]ethyl Hexadecanoate
11. 10-(3-(4-(2-hydroxyethyl)piperidino)propyl)-n,n-dimethylphenothiazine-2-sulfonamide Palmitate (ester)
12. Ncgc00182048-01
13. 2-[1-[3-[2-[(dimethylamino)sulphonyl]-10h-phenothiazin-10-yl]propyl]piperidin-4-yl]ethyl Palmitate
14. Hexadecanoic Acid, 2-(1-(3-(2-((dimethylamino)sulfonyl)-10h-phenothiazin-10-yl)propyl)-4-piperidinyl)ethyl Ester
15. Pipotiazine Palmitate (usan)
16. Piportil Depot
17. 2-(1-(3-(2-((dimethylamino)sulphonyl)-10h-phenothiazin-10-yl)propyl)piperidin-4-yl)ethyl Palmitate
18. Il 19552
19. Einecs 253-536-4
20. Unii-4q3h01qrmi
21. Pipotiazin Retard
22. Pipotiazine-palmitate
23. Pipothiazin Palmitate
24. Piportil Depot (tn)
25. Dsstox_cid_28896
26. Dsstox_rid_83164
27. Dsstox_gsid_48970
28. Schembl636669
29. Chembl2106439
30. Dtxsid5048970
31. Chebi:135769
32. Zinc8214658
33. Tox21_113420
34. Pipotiazine Palmitate [mart.]
35. Akos015962982
36. Pipotiazine Palmitate [who-dd]
37. Ac-1270
38. Pipotiazine Palmitic Ester [mi]
39. Cas-37517-26-3
40. Ft-0673939
41. D02680
42. Sr-01000944866
43. Sr-01000944866-1
44. Q27260354
45. 2-[1-[3-[2-[(dimethylamino)sulphonyl]-10h-phenothiazin-10-yl]propyl]piperidin-4-yl]ethylpalmitate
46. Palmitic Acid 2-[1-[3-[2-[(dimethylamino)sulfonyl]-10h-phenothiazin-10-yl]propyl]-4-piperidinyl]ethyl Ester
| Molecular Weight | 714.1 g/mol |
|---|---|
| Molecular Formula | C40H63N3O4S2 |
| XLogP3 | 11.6 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 24 |
| Exact Mass | 713.42599985 g/mol |
| Monoisotopic Mass | 713.42599985 g/mol |
| Topological Polar Surface Area | 104 Ų |
| Heavy Atom Count | 49 |
| Formal Charge | 0 |
| Complexity | 1010 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Market Place
ABOUT THIS PAGE
A Pipotiazine Palmitate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pipotiazine Palmitate, including repackagers and relabelers. The FDA regulates Pipotiazine Palmitate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pipotiazine Palmitate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pipotiazine Palmitate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pipotiazine Palmitate supplier is an individual or a company that provides Pipotiazine Palmitate active pharmaceutical ingredient (API) or Pipotiazine Palmitate finished formulations upon request. The Pipotiazine Palmitate suppliers may include Pipotiazine Palmitate API manufacturers, exporters, distributors and traders.
click here to find a list of Pipotiazine Palmitate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pipotiazine Palmitate DMF (Drug Master File) is a document detailing the whole manufacturing process of Pipotiazine Palmitate active pharmaceutical ingredient (API) in detail. Different forms of Pipotiazine Palmitate DMFs exist exist since differing nations have different regulations, such as Pipotiazine Palmitate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pipotiazine Palmitate DMF submitted to regulatory agencies in the US is known as a USDMF. Pipotiazine Palmitate USDMF includes data on Pipotiazine Palmitate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pipotiazine Palmitate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pipotiazine Palmitate suppliers with USDMF on PharmaCompass.
Pipotiazine Palmitate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pipotiazine Palmitate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pipotiazine Palmitate GMP manufacturer or Pipotiazine Palmitate GMP API supplier for your needs.
A Pipotiazine Palmitate CoA (Certificate of Analysis) is a formal document that attests to Pipotiazine Palmitate's compliance with Pipotiazine Palmitate specifications and serves as a tool for batch-level quality control.
Pipotiazine Palmitate CoA mostly includes findings from lab analyses of a specific batch. For each Pipotiazine Palmitate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pipotiazine Palmitate may be tested according to a variety of international standards, such as European Pharmacopoeia (Pipotiazine Palmitate EP), Pipotiazine Palmitate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pipotiazine Palmitate USP).
LOOKING FOR A SUPPLIER?
